Dysregulation of m1A regulators is closely related to glioma development and progression, and inhibition of TRMT6, a methyltransferase of m1A, inhibits glioma cell proliferation, migration, and invasion (Wang et al., 2021c). Here, TRMT6 is linked to central nervous system cancer.